Amedeo Smart

Free Medical Literature Service


 

Amedeo

Influenza

  Free Subscription

09.08.2021

1 Am J Med
4 Arch Virol
1 Biochemistry
1 BMJ
2 Cell
1 Epidemiol Infect
3 J Epidemiol Community Health
1 J Exp Med
2 J Immunol
4 J Infect
3 J Infect Dis
1 J Virol
1 J Virol Methods
11 Lancet
3 N Engl J Med
4 Pediatrics
1 PLoS Biol
4 PLoS Comput Biol
72 PLoS One
13 Proc Natl Acad Sci U S A
13 Vaccine



    Am J Med

  1. QUINN MJ
    Clinical Omissions in COVID-19.
    Am J Med. 2021;134:e463.
    >> Share


    Arch Virol

  2. LAVERACK M, Tallmadge RL, Venugopalan R, Cronk B, et al
    Clinical evaluation of a multiplex real-time RT-PCR assay for detection of SARS-CoV-2 in individual and pooled upper respiratory tract samples.
    Arch Virol. 2021;166:2551-2561.
    >> Share

  3. NAGY A, Basiouni S, Parvin R, Hafez HM, et al
    Evolutionary insights into the furin cleavage sites of SARS-CoV-2 variants from humans and animals.
    Arch Virol. 2021;166:2541-2549.
    >> Share

  4. MARCHIO A, Batejat C, Vanhomwegen J, Feher M, et al
    ddPCR increases detection of SARS-CoV-2 RNA in patients with low viral loads.
    Arch Virol. 2021;166:2529-2540.
    >> Share

  5. ABDELWAHAB SF, Mohamed MK, Ali WY, Ali AS, et al
    Role of polymeric materials in preventing COVID-19 infection.
    Arch Virol. 2021;166:2487-2493.
    >> Share


    Biochemistry

  6. THOMASTON JL, Samways ML, Konstantinidi A, Ma C, et al
    Rimantadine Binds to and Inhibits the Influenza A M2 Proton Channel without Enantiomeric Specificity.
    Biochemistry. 2021 Aug 3. doi: 10.1021/acs.biochem.1c00437.
    >> Share


    BMJ

  7. CROOK H, Raza S, Nowell J, Young M, et al
    Long covid-mechanisms, risk factors, and management.
    BMJ. 2021;374:n1648.
    >> Share


    Cell

  8. WEINGARTEN-GABBAY S, Klaeger S, Sarkizova S, Pearlman LR, et al
    Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.
    Cell. 2021;184:3962-3980.
    >> Share

  9. COPIN R, Baum A, Wloga E, Pascal KE, et al
    The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.
    Cell. 2021;184:3949-3961.
    >> Share


    Epidemiol Infect

  10. YAKOB L
    Isolation thresholds for curbing SARS-CoV-2 resurgence.
    Epidemiol Infect. 2021;149:e168.
    >> Share


    J Epidemiol Community Health

  11. MACDONALD I, Hsu JL
    Epidemiological observations on breaking COVID-19 transmission: from the experience of Taiwan.
    J Epidemiol Community Health. 2021;75:809-812.
    >> Share

  12. DARAS K, Alexiou A, Rose TC, Buchan I, et al
    How does vulnerability to COVID-19 vary between communities in England? Developing a Small Area Vulnerability Index (SAVI).
    J Epidemiol Community Health. 2021;75:729-734.
    >> Share

  13. ABURTO JM, Kashyap R, Scholey J, Angus C, et al
    Estimating the burden of the COVID-19 pandemic on mortality, life expectancy and lifespan inequality in England and Wales: a population-level analysis.
    J Epidemiol Community Health. 2021;75:735-740.
    >> Share


    J Exp Med

  14. AHN M, Wang LF
    Translation from bats to humans beyond infectious diseases.
    J Exp Med. 2021;218.
    >> Share


    J Immunol

  15. REYNOLDS D, Vazquez Guillamet C, Day A, Borcherding N, et al
    Comprehensive Immunologic Evaluation of Bronchoalveolar Lavage Samples from Human Patients with Moderate and Severe Seasonal Influenza and Severe COVID-19.
    J Immunol. 2021 Aug 4. pii: jimmunol.2100294. doi: 10.4049/jimmunol.2100294.
    >> Share

  16. MALINCZAK CA, Parolia A, Fonseca W, Morris S, et al
    TSLP-Driven Chromatin Remodeling and Trained Systemic Immunity after Neonatal Respiratory Viral Infection.
    J Immunol. 2021;206:1315-1328.
    >> Share


    J Infect

  17. BARBOSA GR, Moreira LVL, Justo AFO, Perosa AH, et al
    Rapid spread and high impact of the variant of concern P.1 in the largest city of Brazil.
    J Infect. 2021;83:119-145.
    >> Share

  18. FERNANDEZ-DE-LAS-PENAS C, Torres-Macho J, Velasco-Arribas M, Arias-Navalon JA, et al
    Similar prevalence of long-term post-COVID symptoms in patients with asthma: A case-control study.
    J Infect. 2021;83:237-279.
    >> Share

  19. FERNANDEZ-DE-LAS-PENAS C, Palacios-Cena D, Gomez-Mayordomo V, Rodriuez-Jimenez J, et al
    Long-term post-COVID symptoms and associated risk factors in previously hospitalized patients: A multicenter study.
    J Infect. 2021;83:237-279.
    >> Share

  20. CHEN J, Li X, Xu L, Xie S, et al
    Health threats from increased antigenicity changes in H5N6-dominant subtypes, 2020 China.
    J Infect. 2021;83:e9-e11.
    >> Share


    J Infect Dis

  21. SOUTHWICK FS
    Improving the Definition of Coronavirus Disease 2019-Related Deaths.
    J Infect Dis. 2021;224:375-376.
    >> Share

  22. AVIV R, Weber A, Anzum T, Federbush M, et al
    Prolonged Coronavirus Disease 2019 in a Patient With Rheumatoid Arthritis on Rituximab Therapy.
    J Infect Dis. 2021;224:557-559.
    >> Share

  23. ALLAN-BLITZ LT, Klausner JD
    Reply: Seroprevalence of SARS-CoV-2 After the Largest Initial Epidemic Wave in the United States: Findings from New York City, May 13-July 21, 2020.
    J Infect Dis. 2021;224:556-557.
    >> Share


    J Virol

  24. OU J, Zhou Z, Dai R, Zhang J, et al
    V367F mutation in SARS-CoV-2 spike RBD emerging during the early transmission phase enhances viral infectivity through increased human ACE2 receptor binding affinity.
    J Virol. 2021 Jun 2:JVI0061721. doi: 10.1128/JVI.00617.
    >> Share


    J Virol Methods

  25. FINCH J, Zuckerman M, Smith M
    Investigating the sequence variation in the influenza A matrix genes during the 2017-2018 and 2018-2019 seasons in samples from a local population in London.
    J Virol Methods. 2021;297:114250.
    >> Share


    Lancet

  26. FLOWER B, Atchison C
    SARS-CoV-2 antibody seroprevalence in patients receiving dialysis in the USA.
    Lancet. 2020 Sep 25. pii: S0140-6736(20)32006.
    >> Share

  27. CAO B, Hayden FG
    Antiviral monotherapy for hospitalised patients with COVID-19 is not enough.
    Lancet. 2020 Oct 5. pii: S0140-6736(20)32078.
    >> Share

  28. CARLET J, Payen D, Opal SM
    Steroids for sepsis and ARDS: this eternal controversy remains with COVID-19.
    Lancet. 2020 Oct 9. pii: S0140-6736(20)32132.
    >> Share

  29. THE LANCET
    Health in the USA: under examination and under repair.
    Lancet. 2021;397:641.
    >> Share

  30. DAS P
    Sharrelle Barber: at the intersection of place, race, and health.
    Lancet. 2021;397:659.
    >> Share

  31. MMONU NA, Aifah A, Onakomaiya D, Ogedegbe G, et al
    Why the global health community should support the EndSARS movement in Nigeria.
    Lancet. 2021;397:666-667.
    >> Share

  32. KENTOR RA, Thompson AL
    Answering the call to support youth orphaned by COVID-19.
    Lancet. 2021 Jul 20. pii: S0140-6736(21)01446.
    >> Share

  33. JAUREGUI A, Lambert EV, Panter J, Moore C, et al
    Scaling up urban infrastructure for physical activity in the COVID-19 pandemic and beyond.
    Lancet. 2021 Jul 21. pii: S0140-6736(21)01599.
    >> Share

  34. LURIE N, Keusch GT, Dzau VJ
    Should global financing be the main priority for pandemic preparedness? - Authors' reply.
    Lancet. 2021;398:388-389.
    >> Share

  35. PAN D, Martin CA, Nazareth J, Nevill CR, et al
    Ethnic disparities in COVID-19: increased risk of infection or severe disease?
    Lancet. 2021;398:389-390.
    >> Share

  36. MATHUR R, Rentsch CT, Morton CE, Eggo RM, et al
    Ethnic disparities in COVID-19: increased risk of infection or severe disease? - Authors' reply.
    Lancet. 2021;398:390.
    >> Share


    N Engl J Med

  37. NACHEGA JB, Sam-Agudu NA, Mellors JW, Zumla A, et al
    Scaling Up Covid-19 Vaccination in Africa - Lessons from the HIV Pandemic.
    N Engl J Med. 2021 Mar 31. doi: 10.1056/NEJMp2103313.
    >> Share

  38. STRUYF F, Sadoff J, Douoguih M
    ChAdOx1 nCoV-19 Vaccine Efficacy against the B.1.351 Variant.
    N Engl J Med. 2021;385.
    >> Share

  39. MADHI SA, Izu A, Pollard AJ
    ChAdOx1 nCoV-19 Vaccine Efficacy against the B.1.351 Variant. Reply.
    N Engl J Med. 2021;385.
    >> Share


    Pediatrics

  40. CHUA KP, Volerman A, Conti RM
    Prescription Drug Dispensing to US Children During the COVID-19 Pandemic.
    Pediatrics. 2021;148.
    >> Share

  41. LANPHIER E, Mosley L, Antommaria AHM
    Assessing Visitor Policy Exemption Requests During the COVID-19 Pandemic.
    Pediatrics. 2021;148.
    >> Share

  42. FITZPATRICK T, McNally JD, Stukel TA, Lu H, et al
    Family and Child Risk Factors for Early-Life RSV Illness.
    Pediatrics. 2021;147.
    >> Share

  43. RAMBAUD J, Dauger S, Morin L, Bergounioux J, et al
    Bronchiolitis Admissions to Intensive Care During COVID.
    Pediatrics. 2021 Mar 17. pii: peds.2021-050103. doi: 10.1542/peds.2021-050103.
    >> Share


    PLoS Biol

  44. KISSLER SM, Fauver JR, Mack C, Olesen SW, et al
    Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies.
    PLoS Biol. 2021;19:e3001333.
    >> Share


    PLoS Comput Biol

  45. CHERIAN P, Krishna S, Menon GI
    Optimizing testing for COVID-19 in India.
    PLoS Comput Biol. 2021;17:e1009126.
    >> Share

  46. GIBBS H, Nightingale E, Liu Y, Cheshire J, et al
    Detecting behavioural changes in human movement to inform the spatial scale of interventions against COVID-19.
    PLoS Comput Biol. 2021;17:e1009162.
    >> Share

  47. LI T, White LF
    Bayesian back-calculation and nowcasting for line list data during the COVID-19 pandemic.
    PLoS Comput Biol. 2021;17:e1009210.
    >> Share

  48. NAUMOV V, Putin E, Pushkov S, Kozlova E, et al
    COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.
    PLoS Comput Biol. 2021;17:e1009183.
    >> Share


    PLoS One

  49. HEUVELINE P
    The Mean Unfulfilled Lifespan (MUL): A new indicator of the impact of mortality shocks on the individual lifespan, with application to mortality reversals induced by COVID-19.
    PLoS One. 2021;16:e0254925.
    >> Share

  50. FURTH N, Shilo S, Cohen N, Erez N, et al
    Unified platform for genetic and serological detection of COVID-19 with single-molecule technology.
    PLoS One. 2021;16:e0255096.
    >> Share

  51. HEIDEL A, Hagist C, Schlereth C
    Pricing through health apps generated data-Digital dividend as a game changer: Discrete choice experiment.
    PLoS One. 2021;16:e0254786.
    >> Share

  52. SCHMUCK J, Hiebel N, Rabe M, Schneider J, et al
    Sense of coherence, social support and religiosity as resources for medical personnel during the COVID-19 pandemic: A web-based survey among 4324 health care workers within the German Network University Medicine.
    PLoS One. 2021;16:e0255211.
    >> Share

  53. MARTINEZ D, Parilli C, Rojas AM, Scartascini C, et al
    Do you have COVID-19? How to increase the use of diagnostic and contact tracing apps.
    PLoS One. 2021;16:e0253490.
    >> Share

  54. ABOUMRAD M, Shiner B, Riblet N, Huizenga H, et al
    Trends in COVID-19 cases and clinical management in Veterans Health Administration medical facilities: A national cohort study.
    PLoS One. 2021;16:e0246217.
    >> Share

  55. MALLARI RJ, Avery MB, Corlin A, Eisenberg A, et al
    Streamlining brain tumor surgery care during the COVID-19 pandemic: A case-control study.
    PLoS One. 2021;16:e0254958.
    >> Share

  56. MARMET S, Wicki M, Gmel G, Gachoud C, et al
    The psychological impact of the COVID-19 crisis is higher among young Swiss men with a lower socioeconomic status: Evidence from a cohort study.
    PLoS One. 2021;16:e0255050.
    >> Share

  57. AREVALOS V, Ortega-Paz L, Fernandez-Rodriguez D, Alfonso Jimenez-Diaz V, et al
    Long-term effects of coronavirus disease 2019 on the cardiovascular system, CV COVID registry: A structured summary of a study protocol.
    PLoS One. 2021;16:e0255263.
    >> Share

  58. BOU-HAMAD I, Hoteit R, Harajli D
    Health worries, life satisfaction, and social well-being concerns during the COVID-19 pandemic: Insights from Lebanon.
    PLoS One. 2021;16:e0254989.
    >> Share

  59. HLEDIK M, Polechova J, Beiglbock M, Herdina AN, et al
    Analysis of the specificity of a COVID-19 antigen test in the Slovak mass testing program.
    PLoS One. 2021;16:e0255267.
    >> Share

  60. YADAV UN, Yadav OP, Singh DR, Ghimire S, et al
    Perceived fear of COVID-19 and its associated factors among Nepalese older adults in eastern Nepal: A cross-sectional study.
    PLoS One. 2021;16:e0254825.
    >> Share

  61. LIU X, Ahmad Z, Gemeay AM, Abdulrahman AT, et al
    Modeling the survival times of the COVID-19 patients with a new statistical model: A case study from China.
    PLoS One. 2021;16:e0254999.
    >> Share

  62. COZIER YC, Castro-Webb N, Hochberg NS, Rosenberg L, et al
    Lower serum 25(OH)D levels associated with higher risk of COVID-19 infection in U.S. Black women.
    PLoS One. 2021;16:e0255132.
    >> Share

  63. BSTEH G, Assar H, Hegen H, Heschl B, et al
    COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry.
    PLoS One. 2021;16:e0255316.
    >> Share

  64. KOOB C, Schropfer K, Coenen M, Kus S, et al
    Factors influencing study engagement during the COVID-19 pandemic: A cross-sectional study among health and social professions students.
    PLoS One. 2021;16:e0255191.
    >> Share

  65. RAHMAN MA, Shanjana Y, Tushar MI, Mahmud T, et al
    Hematological abnormalities and comorbidities are associated with COVID-19 severity among hospitalized patients: Experience from Bangladesh.
    PLoS One. 2021;16:e0255379.
    >> Share

  66. YU Y, Li C, Yang W, Xu W, et al
    Determining the critical factors of air-conditioning innovation using an integrated model of fuzzy Kano-QFD during the COVID-19 pandemic: The perspective of air purification.
    PLoS One. 2021;16:e0255051.
    >> Share

  67. PATUELLI A, Caldarelli G, Lattanzi N, Saracco F, et al
    Firms' challenges and social responsibilities during Covid-19: A Twitter analysis.
    PLoS One. 2021;16:e0254748.
    >> Share

  68. WISSMATH B, Mast FW, Kraus F, Weibel D, et al
    Understanding the psychological impact of the COVID-19 pandemic and containment measures: An empirical model of stress.
    PLoS One. 2021;16:e0254883.
    >> Share

  69. FLINSPACH AN, Booke H, Zacharowski K, Balaban U, et al
    High sedation needs of critically ill COVID-19 ARDS patients-A monocentric observational study.
    PLoS One. 2021;16:e0253778.
    >> Share

  70. MARY-KRAUSE M, Herranz Bustamante JJ, Heron M, Andersen AJ, et al
    Impact of COVID-19-like symptoms on occurrence of anxiety/depression during lockdown among the French general population.
    PLoS One. 2021;16:e0255158.
    >> Share

  71. BABICKA-WIRKUS A, Wirkus L, Stasiak K, Kozlowski P, et al
    University students' strategies of coping with stress during the coronavirus pandemic: Data from Poland.
    PLoS One. 2021;16:e0255041.
    >> Share

  72. YANG XD, Su XY, Li HL, Ma RF, et al
    Impacts of socio-economic determinants, spatial distance and climate factors on the confirmed cases and deaths of COVID-19 in China.
    PLoS One. 2021;16:e0255229.
    >> Share

  73. HOU C, Jiang H
    Methodology of emergency medical logistics for multiple epidemic areas in public health emergency.
    PLoS One. 2021;16:e0253978.
    >> Share

  74. SHAULY-AHARONOV M, Shafrir A, Paltiel O, Calderon-Margalit R, et al
    Both high and low pre-infection glucose levels associated with increased risk for severe COVID-19: New insights from a population-based study.
    PLoS One. 2021;16:e0254847.
    >> Share

  75. DESVAUX E, Hamon A, Hubert S, Boudjeniba C, et al
    Network-based repurposing identifies anti-alarmins as drug candidates to control severe lung inflammation in COVID-19.
    PLoS One. 2021;16:e0254374.
    >> Share

  76. GHONIMI TAL, Alkad MM, Abuhelaiqa EA, Othman MM, et al
    Mortality and associated risk factors of COVID-19 infection in dialysis patients in Qatar: A nationwide cohort study.
    PLoS One. 2021;16:e0254246.
    >> Share

  77. SCARPINA F, Godi M, Corna S, Seitanidis I, et al
    Psychological functioning in survivors of COVID-19: Evidence from recognition of fearful facial expressions.
    PLoS One. 2021;16:e0254438.
    >> Share

  78. AVARI P, Unsworth R, Rilstone S, Uduku C, et al
    Improved glycaemia during the Covid-19 pandemic lockdown is sustained post-lockdown and during the "Eat Out to Help Out" Government Scheme, in adults with Type 1 diabetes in the United Kingdom.
    PLoS One. 2021;16:e0254951.
    >> Share

  79. CHEN PY, Ko CH, Wang CJ, Chen CW, et al
    The early detection of immunoglobulins via optical-based lateral flow immunoassay platform in COVID-19 pandemic.
    PLoS One. 2021;16:e0254486.
    >> Share

  80. STRASSER S, Stauber C, Shrivastava R, Riley P, et al
    Collective insights of public-private partnership impacts and sustainability: A qualitative analysis.
    PLoS One. 2021;16:e0254495.
    >> Share

  81. ZHOU Y, O'Leary TJ
    Relative sensitivity of anterior nares and nasopharyngeal swabs for initial detection of SARS-CoV-2 in ambulatory patients: Rapid review and meta-analysis.
    PLoS One. 2021;16:e0254559.
    >> Share

  82. GROSSMANN G, Backenkohler M, Wolf V
    Heterogeneity matters: Contact structure and individual variation shape epidemic dynamics.
    PLoS One. 2021;16:e0250050.
    >> Share

  83. GUAN G, Dery Y, Yechezkel M, Ben-Gal I, et al
    Early detection of COVID-19 outbreaks using human mobility data.
    PLoS One. 2021;16:e0253865.
    >> Share

  84. SANCHEZ-ARENAS R, Doubova SV, Gonzalez-Perez MA, Perez-Cuevas R, et al
    Factors associated with COVID-19 preventive health behaviors among the general public in Mexico City and the State of Mexico.
    PLoS One. 2021;16:e0254435.
    >> Share

  85. GUO K, Zhang X, Bai S, Minhat HS, et al
    Assessing social support impact on depression, anxiety, and stress among undergraduate students in Shaanxi province during the COVID-19 pandemic of China.
    PLoS One. 2021;16:e0253891.
    >> Share

  86. KEIL R, Hlava S, Stanovsky P, Zdimal V, et al
    Commonly available but highly effective protection against SARS-CoV-2 during gastrointestinal endoscopies.
    PLoS One. 2021;16:e0254979.
    >> Share

  87. JANAKA SK, Clark NM, Evans DT, Mou H, et al
    Predicting the efficacy of COVID-19 convalescent plasma donor units with the Lumit Dx anti-receptor binding domain assay.
    PLoS One. 2021;16:e0253551.
    >> Share

  88. WEAVER DT, McElvany BD, Gopalakrishnan V, Card KJ, et al
    UV decontamination of personal protective equipment with idle laboratory biosafety cabinets during the COVID-19 pandemic.
    PLoS One. 2021;16:e0241734.
    >> Share

  89. TASAKIS RN, Samaras G, Jamison A, Lee M, et al
    SARS-CoV-2 variant evolution in the United States: High accumulation of viral mutations over time likely through serial Founder Events and mutational bursts.
    PLoS One. 2021;16:e0255169.
    >> Share

  90. MEIS-PINHEIRO U, Lopez-Segui F, Walsh S, Ussi A, et al
    Clinical characteristics of COVID-19 in older adults. A retrospective study in long-term nursing homes in Catalonia.
    PLoS One. 2021;16:e0255141.
    >> Share

  91. HOEK JM, Field SM, de Vries YA, Linde M, et al
    Rethinking remdesivir for COVID-19: A Bayesian reanalysis of trial findings.
    PLoS One. 2021;16:e0255093.
    >> Share

  92. SCHNELL E, Karamooz E, Harriff MJ, Yates JE, et al
    Construction and validation of an ultraviolet germicidal irradiation system using locally available components.
    PLoS One. 2021;16:e0255123.
    >> Share

  93. BONOMI BEZZO F, Silva L, van Ham M
    The combined effect of Covid-19 and neighbourhood deprivation on two dimensions of subjective well-being: Empirical evidence from England.
    PLoS One. 2021;16:e0255156.
    >> Share

  94. IJKEMA R, Janssens MJPA, van der Post JAM, Licht CM, et al
    Ethical review of COVID-19 research in the Netherlands; a mixed-method evaluation among medical research ethics committees and investigators.
    PLoS One. 2021;16:e0255040.
    >> Share

  95. DIXON BE, Grannis SJ, Lembcke LR, Valvi N, et al
    The synchronicity of COVID-19 disparities: Statewide epidemiologic trends in SARS-CoV-2 morbidity, hospitalization, and mortality among racial minorities and in rural America.
    PLoS One. 2021;16:e0255063.
    >> Share

  96. COSTA ML, Souza RT, Pacagnella RC, Bento SF, et al
    Facing the COVID-19 pandemic inside maternities in Brazil: A mixed-method study within the REBRACO initiative.
    PLoS One. 2021;16:e0254977.
    >> Share

  97. MARTINEZ ME, Capella Gonzalez C, Huey D, Peeples ME, et al
    Immunogenicity and inflammatory properties of respiratory syncytial virus attachment G protein in cotton rats.
    PLoS One. 2021;16:e0246770.
    >> Share

  98. SWAIN PK, Tripathy MR, Priyadarshini S, Acharya SK, et al
    Forecasting suicide rates in India: An empirical exposition.
    PLoS One. 2021;16:e0255342.
    >> Share

  99. GALARNEAU LR, Hilburt J, O'Neill ZR, Buxton JA, et al
    Experiences of people with opioid use disorder during the COVID-19 pandemic: A qualitative study.
    PLoS One. 2021;16:e0255396.
    >> Share

  100. HU D, Zhang H, Sun Y, Li Y, et al
    The effects of the measures against COVID-19 pandemic on physical activity among school-aged children and adolescents (6-17 years) in 2020: A protocol for systematic review.
    PLoS One. 2021;16:e0255520.
    >> Share

  101. NGUYEN HTT, Dinh DX, Nguyen VM
    Knowledge, attitude and practices of community pharmacists regarding COVID-19: A paper-based survey in Vietnam.
    PLoS One. 2021;16:e0255420.
    >> Share

  102. MIRAGLIA JL, Nascimento Monteiro C, Giannecchini Romagnolo A, Xavier Gomes R, et al
    A seroprevalence survey of anti-SARS-CoV-2 antibodies among individuals 18 years of age or older living in a vulnerable region of the city of Sao Paulo, Brazil.
    PLoS One. 2021;16:e0255412.
    >> Share

  103. MARQUIONI VM, de Aguiar MAM
    Modeling neutral viral mutations in the spread of SARS-CoV-2 epidemics.
    PLoS One. 2021;16:e0255438.
    >> Share

  104. RAHMAN T, Hasnain MDG, Islam A
    Food insecurity and mental health of women during COVID-19: Evidence from a developing country.
    PLoS One. 2021;16:e0255392.
    >> Share

  105. TAGHIOFF SM, Slavin BR, Holton T, Singh D, et al
    Examining the potential benefits of the influenza vaccine against SARS-CoV-2: A retrospective cohort analysis of 74,754 patients.
    PLoS One. 2021;16:e0255541.
    >> Share

  106. AKHTAR Z, Chowdhury F, Rahman M, Ghosh PK, et al
    Seasonal influenza during the COVID-19 pandemic in Bangladesh.
    PLoS One. 2021;16:e0255646.
    >> Share

  107. ABREU RB, Kirchenbaum GA, Sautto GA, Clutter EF, et al
    Impaired memory B-cell recall responses in the elderly following recurrent influenza vaccination.
    PLoS One. 2021;16:e0254421.
    >> Share

  108. BOUDOU M, OhAiseadha C, Garvey P, O'Dwyer J, et al
    Breakpoint modelling of temporal associations between non-pharmaceutical interventions and symptomatic COVID-19 incidence in the Republic of Ireland.
    PLoS One. 2021;16:e0255254.
    >> Share

  109. ARAMBEPOLA C, Wickramasinghe ND, Jayakody S, Hewage SA, et al
    Sri Lanka's early success in the containment of COVID-19 through its rapid response: Clinical & epidemiological evidence from the initial case series.
    PLoS One. 2021;16:e0255394.
    >> Share

  110. POSTIGO-ZEGARRA S, Julian M, Schoeps K, Montoya-Castilla I, et al
    Psychological adjustment of Spanish adolescents and their parents during COVID-19 lockdown: A mixed method approach.
    PLoS One. 2021;16:e0255149.
    >> Share

  111. EL HAGE J, Gravitt P, Ravel J, Lahrichi N, et al
    Supporting scale-up of COVID-19 RT-PCR testing processes with discrete event simulation.
    PLoS One. 2021;16:e0255214.
    >> Share

  112. LEE CM, Juarez M, Rae G, Jones L, et al
    Anxiety, PTSD, and stressors in medical students during the initial peak of the COVID-19 pandemic.
    PLoS One. 2021;16:e0255013.
    >> Share

  113. MISTRY SK, Ali ARMM, Yadav UN, Ghimire S, et al
    Older adults with non-communicable chronic conditions and their health care access amid COVID-19 pandemic in Bangladesh: Findings from a cross-sectional study.
    PLoS One. 2021;16:e0255534.
    >> Share

  114. KATZENSCHLAGER S, Zimmer AJ, Gottschalk C, Grafeneder J, et al
    Can we predict the severe course of COVID-19 - a systematic review and meta-analysis of indicators of clinical outcome?
    PLoS One. 2021;16:e0255154.
    >> Share

  115. HABIBI M, Taheri G
    Topological network based drug repurposing for coronavirus 2019.
    PLoS One. 2021;16:e0255270.
    >> Share

  116. KLEITMAN S, Fullerton DJ, Zhang LM, Blanchard MD, et al
    To comply or not comply? A latent profile analysis of behaviours and attitudes during the COVID-19 pandemic.
    PLoS One. 2021;16:e0255268.
    >> Share

  117. WILDE H, Dennis JM, McGovern AP, Vollmer SJ, et al
    A national retrospective study of the association between serious operational problems and COVID-19 specific intensive care mortality risk.
    PLoS One. 2021;16:e0255377.
    >> Share

  118. RAINES KS, Doniach S, Bhanot G
    The transmission of SARS-CoV-2 is likely comodulated by temperature and by relative humidity.
    PLoS One. 2021;16:e0255212.
    >> Share

  119. ZHANG Y, Khullar D, Wang F, Steel P, et al
    Socioeconomic variation in characteristics, outcomes, and healthcare utilization of COVID-19 patients in New York City.
    PLoS One. 2021;16:e0255171.
    >> Share

  120. WADHWA A, Yin S, Freeman B, Hershow RB, et al
    Comparison of the SARS-CoV-2 spike protein ELISA and the Abbott Architect SARS-CoV-2 IgG nucleocapsid protein assays for detection of antibodies.
    PLoS One. 2021;16:e0255208.
    >> Share


    Proc Natl Acad Sci U S A

  121. HAN X, Xu Y, Fan L, Huang Y, et al
    Quantifying COVID-19 importation risk in a dynamic network of domestic cities and international countries.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  122. PETERSEN MB, Bor A, Jorgensen F, Lindholt MF, et al
    Transparent communication about negative features of COVID-19 vaccines decreases acceptance but increases trust.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  123. ZHANG H, Zhu W, Jin Q, Pan F, et al
    Inhalable nanocatchers for SARS-CoV-2 inhibition.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  124. ROCHMAN ND, Wolf YI, Faure G, Mutz P, et al
    Ongoing global and regional adaptive evolution of SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  125. IRONS NJ, Raftery AE
    Estimating SARS-CoV-2 infections from deaths, confirmed cases, tests, and random surveys.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  126. PINK SL, Chu J, Druckman JN, Rand DG, et al
    Elite party cues increase vaccination intentions among Republicans.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  127. ASHWORTH M, Thunstrom L, Cherry TL, Newbold SC, et al
    Emphasize personal health benefits to boost COVID-19 vaccination rates.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  128. ARCHIBONG B, Metcalf CJE
    Building toward useful SARS-CoV-2 models in Africa.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  129. AGARWAL R, Dugas M, Ramaprasad J, Luo J, et al
    Socioeconomic privilege and political ideology are associated with racial disparity in COVID-19 vaccination.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  130. PARRY R, Gifford RJ, Lytras S, Ray SC, et al
    No evidence of SARS-CoV-2 reverse transcription and integration as the origin of chimeric transcripts in patient tissues.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  131. ZHANG L, Richards A, Barrasa MI, Hughes SH, et al
    Response to Parry et al.: Strong evidence for genomic integration of SARS-CoV-2 sequences and expression in patient tissues.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  132. KERR GH, Goldberg DL, Anenberg SC
    COVID-19 pandemic reveals persistent disparities in nitrogen dioxide pollution.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  133. BAKER A, Biazzo I, Braunstein A, Catania G, et al
    Epidemic mitigation by statistical inference from contact tracing data.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share


    Vaccine

  134. REDONDO E, Drago G, Lopez-Belmonte JL, Guillen JM, et al
    Cost-utility analysis of influenza vaccination in a population aged 65 years or older in Spain with a high-dose vaccine versus an adjuvanted vaccine.
    Vaccine. 2021 Jul 31. pii: S0264-410X(21)00926.
    >> Share

  135. HSIA J, Zhao G, Lu PJ, Town M, et al
    Estimating bias from internet non-use for a hybrid web vaccination survey - 2013-2017 Behavioral Risk Factor Surveillance System.
    Vaccine. 2021 Jun 11. pii: S0264-410X(21)00675.
    >> Share

  136. IVANOV V, Oomens AGP, Papin JF, Staats R, et al
    Intranasal and intrapulmonary vaccination with an M protein-deficient respiratory syncytial virus (RSV) vaccine improves clinical signs and reduces viral replication in infant baboons after an RSV challenge infection.
    Vaccine. 2021 Jun 14. pii: S0264-410X(21)00737.
    >> Share

  137. PRASAD N, Read JM, Jewell C, Waite B, et al
    Modelling the impact of respiratory syncytial virus (RSV) vaccine and immunoprophylaxis strategies in New Zealand.
    Vaccine. 2021 Jun 16. pii: S0264-410X(21)00708.
    >> Share

  138. HERVE PL, Dhelft V, Zuniga A, Ghasparian A, et al
    Epicutaneous immunization using synthetic virus-like particles efficiently boosts protective immunity to respiratory syncytial virus.
    Vaccine. 2021;39:4555-4563.
    >> Share

  139. CARCELEN AC, Vilajeliu A, Malik F, Gilman RH, et al
    Perceptions and attitudes towards vaccination during pregnancy in a peri urban area of Lima, Peru.
    Vaccine. 2020 Oct 30. pii: S0264-410X(20)31325.
    >> Share

  140. RAGHUNANDAN R, Higgins D, Hosken N
    RSV neutralization assays - Use in immune response assessment.
    Vaccine. 2021;39:4591-4597.
    >> Share

  141. MATEO-URDIALES A, Del Manso M, Andrianou X, Spuri M, et al
    Initial impact of SARS-Cov-2 vaccination on healthcare workers in Italy- Update on the 28th of March 2021.
    Vaccine. 2021 Jul 7. pii: S0264-410X(21)00862.
    >> Share

  142. GOOCH KE, Smith TRF, Salguero FJ, Fotheringham SA, et al
    One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model.
    Vaccine. 2021 Jun 23. pii: S0264-410X(21)00807.
    >> Share

  143. MACINTYRE CR, Veness B, Berger D, Hamad N, et al
    Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination - A risk-benefit analysis for people < 60 years in Australia.
    Vaccine. 2021 Jul 10. pii: S0264-410X(21)00872.
    >> Share

  144. MOGAJI E
    Marketing the COVID-19 vaccine and the implications for public health.
    Vaccine. 2021 Jul 13. pii: S0264-410X(21)00874.
    >> Share

  145. DIACO M, Yin K, Seet B, Samson S, et al
    Author response to a Letter to the Editor on "Introductory paper: High dose influenza vaccine".
    Vaccine. 2021 Jul 28. pii: S0264-410X(21)00917.
    >> Share

  146. AL-SHAIKH A, Muthu N, Aidyralieva C, Profili MC, et al
    COVID-19 vaccine roll-out in middle-income countries: Lessons learned from the Jordan experience.
    Vaccine. 2021 Jun 29. pii: S0264-410X(21)00840.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016